Standout Papers

Ranibizumab and Bevacizumab fo... 1983 2026 1997 2011 1.4k
  1. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration (2012)
    Daniel Martín, Maureen G. Maguire et al. Ophthalmology
  2. Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration (2016)
    Maureen G. Maguire, Daniel Martín et al. Ophthalmology
  3. Age-related macular degeneration (1988)
    Neil M. Bressler, Susan B. Bressler et al. Survey of Ophthalmology
  4. Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (2013)
    Juan E. Grunwald, Ebenezer Daniel et al. Ophthalmology
  5. SENILE MACULAR DEGENERATION: A CASE-CONTROL STUDY (1983)
    Leslie Hyman, Abraham M. Lilienfeld et al. American Journal of Epidemiology

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 164 standout
Sub-graph 1 of 15

Citing Papers

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
Age-related macular degeneration
2023 Standout
58 intermediate papers

Works of Stuart L. Fine being referenced

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
2013 Standout
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
2013
and 16 more

Author Peers

Author Last Decade Papers Cites
Stuart L. Fine 6475 4549 1588 104 7.4k
G. Coscas 6773 4782 1321 235 7.6k
Andrew Schachat 5266 3053 1009 138 6.3k
Akira Negi 4084 2905 1246 190 5.3k
Carl D. Regillo 6682 5377 1597 218 8.0k
Susan B. Bressler 9147 7237 1687 126 10.1k
Robert L. Avery 7374 5422 2707 76 9.3k
Tatsuro Ishibashi 5269 3681 1880 229 7.1k
Timothy Y. Y. Lai 9815 5851 1294 221 11.0k
G. Soubrane 8974 6355 2204 252 10.3k
Siegfried Priglinger 3643 3116 1115 277 4.9k

All Works

Loading papers...

Rankless by CCL
2026